These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 30055343)

  • 1. LC-MS/MS reveals the formation of iminium and quinone methide reactive intermediates in entrectinib metabolism: In vivo and in vitro metabolic investigation.
    Attwa MW; Kadi AA; Alrabiah H; Darwish HW
    J Pharm Biomed Anal; 2018 Oct; 160():19-30. PubMed ID: 30055343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of Stable and Reactive Metabolites of the Anticancer Drug, Ensartinib, in Human Liver Microsomes Using LC-MS/MS: An in silico and Practical Bioactivation Approach.
    Abdelhameed AS; Attwa MW; Kadi AA
    Drug Des Devel Ther; 2020; 14():5259-5273. PubMed ID: 33299299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Belizatinib: Novel reactive intermediates and bioactivation pathways characterized by LC-MS/MS.
    Attwa MW; Kadi AA; Darwish HW
    J Pharm Biomed Anal; 2019 Jul; 171():132-147. PubMed ID: 30999224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of metabolic degradation of new ALK inhibitor: Entrectinib by LC-MS/MS.
    Attwa MW; Darwish HW; Alhazmi HA; Kadi AA
    Clin Chim Acta; 2018 Oct; 485():298-304. PubMed ID: 30006284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of Fenebrutinib Metabolism and Bioactivation Using MS
    Alsibaee AM; Aljohar HI; Attwa MW; Abdelhameed AS; Kadi AA
    Molecules; 2023 May; 28(10):. PubMed ID: 37241965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of Entrectinib: A New 3-Aminoindazole As a Potent Anaplastic Lymphoma Kinase (ALK), c-ros Oncogene 1 Kinase (ROS1), and Pan-Tropomyosin Receptor Kinases (Pan-TRKs) inhibitor.
    Menichincheri M; Ardini E; Magnaghi P; Avanzi N; Banfi P; Bossi R; Buffa L; Canevari G; Ceriani L; Colombo M; Corti L; Donati D; Fasolini M; Felder E; Fiorelli C; Fiorentini F; Galvani A; Isacchi A; Borgia AL; Marchionni C; Nesi M; Orrenius C; Panzeri A; Pesenti E; Rusconi L; Saccardo MB; Vanotti E; Perrone E; Orsini P
    J Med Chem; 2016 Apr; 59(7):3392-408. PubMed ID: 27003761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LC-MS/MS reveals the formation of reactive ortho-quinone and iminium intermediates in saracatinib metabolism: Phase I metabolic profiling.
    Attwa MW; Kadi AA; Darwish HW; Alrabiah H
    Clin Chim Acta; 2018 Jul; 482():84-94. PubMed ID: 29614307
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection and characterization of olmutinib reactive metabolites by LC-MS/MS: Elucidation of bioactivation pathways.
    Attwa MW; Kadi AA; Abdelhameed AS
    J Sep Sci; 2020 Feb; 43(4):708-718. PubMed ID: 31788977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of phencyclidine in rat and human liver microsomes and recombinant P450 2B enzymes: evidence for the formation of a novel quinone methide intermediate.
    Driscoll JP; Kornecki K; Wolkowski JP; Chupak L; Kalgutkar AS; O'Donnell JP
    Chem Res Toxicol; 2007 Oct; 20(10):1488-97. PubMed ID: 17892269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactive intermediates and bioactivation pathways characterization of avitinib by LC-MS/MS: In vitro metabolic investigation.
    Attwa MW; Kadi AA; Abdelhameed AS
    J Pharm Biomed Anal; 2019 Feb; 164():659-667. PubMed ID: 30472584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the pharmacokinetics of entrectinib and its active M5 metabolite in healthy volunteers and patients with solid tumors.
    Meneses-Lorente G; Bentley D; Guerini E; Kowalski K; Chow-Maneval E; Yu L; Brink A; Djebli N; Mercier F; Buchheit V; Phipps A
    Invest New Drugs; 2021 Jun; 39(3):803-811. PubMed ID: 33462752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways.
    Kadi AA; Attwa MW; Darwish HW
    RSC Adv; 2018 Jan; 8(3):1182-1190. PubMed ID: 35540908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 4-Hydroxylated metabolites of the antiestrogens tamoxifen and toremifene are metabolized to unusually stable quinone methides.
    Fan PW; Zhang F; Bolton JL
    Chem Res Toxicol; 2000 Jan; 13(1):45-52. PubMed ID: 10649966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of
    Al-Shakliah NS; Attwa MW; AlRabiah H; Kadi AA
    Anal Methods; 2021 Jan; 13(3):399-410. PubMed ID: 33410830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Entrectinib: First Global Approval.
    Al-Salama ZT; Keam SJ
    Drugs; 2019 Sep; 79(13):1477-1483. PubMed ID: 31372957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of quinone methide metabolites of dauricine in human liver microsomes and in rat bile.
    Wang Y; Zhong D; Chen X; Zheng J
    Chem Res Toxicol; 2009 May; 22(5):824-34. PubMed ID: 19358519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo metabolic investigation of the Palbociclib by UHPLC-Q-TOF/MS/MS and in silico toxicity studies of its metabolites.
    Chavan BB; Tiwari S; G S; Nimbalkar RD; Garg P; R S; Talluri MVNK
    J Pharm Biomed Anal; 2018 Aug; 157():59-74. PubMed ID: 29772457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entrectinib is a potent inhibitor of Trk-driven neuroblastomas in a xenograft mouse model.
    Iyer R; Wehrmann L; Golden RL; Naraparaju K; Croucher JL; MacFarland SP; Guan P; Kolla V; Wei G; Cam N; Li G; Hornby Z; Brodeur GM
    Cancer Lett; 2016 Mar; 372(2):179-86. PubMed ID: 26797418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolite identification of bentysrepinine (Y101), a novel anti-HBV agent in rats using a five-step strategy based on a combined workflow with two different platforms of liquid chromatography-tandem mass spectrometry.
    Fan H; Hu Z; Li R; Dong S; Gu Y; Liu T; Si D; Liang G; Liu C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():118-128. PubMed ID: 27978466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I metabolic profiling and unexpected reactive metabolites in human liver microsome incubations of X-376 using LC-MS/MS: bioactivation pathway elucidation and
    Attwa MW; Kadi AA; Abdelhameed AS
    RSC Adv; 2020 Jan; 10(9):5412-5427. PubMed ID: 35498318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.